tiprankstipranks
Advertisement
Advertisement

Solara Active Pharma Receives Call Money, Converts Partly Paid Rights Shares

Story Highlights
  • Solara collected about Rs. 93.7 lakh first call money, converting 71,402 rights shares to a higher paid-up status.
  • The company’s paid-up capital has risen to roughly Rs. 44.51 crore, and it will seek listing approvals for converted shares.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Solara Active Pharma Receives Call Money, Converts Partly Paid Rights Shares

Claim 55% Off TipRanks

Solara Active Pharma Sciences Ltd. ( (IN:SOLARA) ) has issued an update.

Solara Active Pharma Sciences Ltd. has received first call money totaling about Rs. 93.7 lakh for 71,402 partly paid-up rights equity shares following a second reminder to shareholders. The Rights Issue Committee has approved converting these shares from Rs. 3.50 paid-up to Rs. 7 paid-up each, increasing the company’s paid-up capital and altering the mix of fully and partly paid shares on its register.

Following this conversion, Solara’s paid-up capital now stands at approximately Rs. 44.51 crore, spread across fully paid and partly paid rights equity shares with different paid-up amounts and ISINs. The company plans to complete the necessary corporate actions to obtain listing and trading approvals for the converted rights equity shares, which will formalize their tradability and further consolidate its capital structure.

More about Solara Active Pharma Sciences Ltd.

Solara Active Pharma Sciences Ltd. operates in the pharmaceutical sector, focusing on active pharmaceutical ingredients and related products for global generic and specialty drug markets. The company is listed on Indian stock exchanges and raises capital through equity, including rights issues, to support its business and growth plans.

Average Trading Volume: 7,617

Technical Sentiment Signal: Sell

Current Market Cap: 22.27B INR

For detailed information about SOLARA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1